DES Health Risks and Precautions - Harvard Health Publications
Links shared publicly online about this topic.
- 1,162total visits
DES Health Risks and Precautions - Harvard Health Publications
In 1971, the FDA warned doctors to stop prescribing DES after it was linked to a rare cancer of the vagina and cervix in the daughters of women who took the drug while pregnant. Many studies since then have confirmed links between DES exposure and various health risks.
View full resource at health.harvard.edu
Tags: Cancer, Drug, Women's Health, Pregnancy, Relationship, FDA, Doctor
Most Recently Shared on May 17, 2010 at 1:38 pm By:
DES health risks and precautions, from Harvard Women's Health Watch - http://bit.ly/9vZtac
Advertisement
